Royal Bank of Canada’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $665M | Sell |
10,958,702
-1,684,783
| -13% | -$98.2M | 0.12% | 167 |
|
|
2025
Q4 | $682M | Sell |
12,643,485
-200,836
| -2% | -$9.66M | 0.11% | 166 |
|
|
2025
Q3 | $579M | Sell |
12,844,321
-1,295,805
| -9% | -$60.5M | 0.09% | 192 |
|
|
2025
Q2 | $655M | Buy |
14,140,126
+761,731
| +6% | +$37.4M | 0.12% | 158 |
|
|
2025
Q1 | $816M | Sell |
13,378,395
-997,516
| -7% | -$58.1M | 0.17% | 120 |
|
|
2024
Q4 | $813M | Buy |
14,375,911
+3,564,580
| +33% | +$199M | 0.16% | 119 |
|
|
2024
Q3 | $559M | Buy |
10,811,331
+3,974,196
| +58% | +$186M | 0.11% | 165 |
|
|
2024
Q2 | $284M | Sell |
6,837,135
-1,069,597
| -14% | -$47.9M | 0.06% | 263 |
|
|
2024
Q1 | $429M | Buy |
7,906,732
+1,078,259
| +16% | +$54.9M | 0.1% | 196 |
|
|
2023
Q4 | $350M | Buy |
6,828,473
+510,017
| +8% | +$26.8M | 0.08% | 222 |
|
|
2023
Q3 | $367M | Sell |
6,318,456
-177,653
| -3% | -$10.9M | 0.1% | 185 |
|
|
2023
Q2 | $415M | Buy |
6,496,109
+612,349
| +10% | +$41.1M | 0.11% | 176 |
|
|
2023
Q1 | $408M | Sell |
5,883,760
-1,165,523
| -17% | -$82.2M | 0.12% | 165 |
|
|
2022
Q4 | $507M | Buy |
7,049,283
+1,100,213
| +18% | +$83M | 0.15% | 138 |
|
|
2022
Q3 | $423M | Sell |
5,949,070
-21,409
| -0.4% | -$1.55M | 0.13% | 146 |
|
|
2022
Q2 | $460M | Buy |
5,970,479
+21,248
| +0.4% | +$1.62M | 0.14% | 144 |
|
|
2022
Q1 | $434M | Sell |
5,949,231
-1,594,504
| -21% | -$107M | 0.11% | 174 |
|
|
2021
Q4 | $470M | Buy |
7,543,735
+1,494,326
| +25% | +$87.7M | 0.11% | 171 |
|
|
2021
Q3 | $358M | Sell |
6,049,409
-1,167,278
| -16% | -$76.9M | 0.09% | 188 |
|
|
2021
Q2 | $482M | Buy |
7,216,687
+840,391
| +13% | +$54.8M | 0.13% | 143 |
|
|
2021
Q1 | $403M | Sell |
6,376,296
-1,048,700
| -14% | -$65.2M | 0.12% | 168 |
|
|
2020
Q4 | $461M | Buy |
7,424,996
+848,835
| +13% | +$52.2M | 0.13% | 150 |
|
|
2020
Q3 | $396M | Buy |
6,576,161
+758,054
| +13% | +$45.6M | 0.14% | 150 |
|
|
2020
Q2 | $342M | Buy |
5,818,107
+153,288
| +3% | +$9.17M | 0.14% | 148 |
|
|
2020
Q1 | $316M | Sell |
5,664,819
-768,499
| -12% | -$47M | 0.15% | 129 |
|
|
2019
Q4 | $413M | Buy |
6,433,318
+307,491
| +5% | +$17.6M | 0.15% | 136 |
|
|
2019
Q3 | $311M | Buy |
6,125,827
+804,932
| +15% | +$37.8M | 0.12% | 154 |
|
|
2019
Q2 | $241M | Sell |
5,320,895
-99,156
| -2% | -$4.62M | 0.1% | 185 |
|
|
2019
Q1 | $259M | Sell |
5,420,051
-929,673
| -15% | -$46.3M | 0.11% | 168 |
|
|
2018
Q4 | $330M | Buy |
6,349,724
+755,172
| +13% | +$40.6M | 0.16% | 125 |
|
|
2018
Q3 | $347M | Sell |
5,594,552
-2,507
| -0% | -$149K | 0.14% | 131 |
|
|
2018
Q2 | $310M | Buy |
5,597,059
+9,000
| +0.2% | +$486K | 0.14% | 135 |
|
|
2018
Q1 | $353M | Buy |
5,588,059
+53,622
| +1% | +$3.45M | 0.16% | 118 |
|
|
2017
Q4 | $339M | Buy |
5,534,437
+749,318
| +16% | +$46.9M | 0.15% | 122 |
|
|
2017
Q3 | $305M | Buy |
4,785,119
+108,699
| +2% | +$6.35M | 0.15% | 129 |
|
|
2017
Q2 | $261M | Buy |
4,676,420
+164,801
| +4% | +$8.97M | 0.13% | 130 |
|
|
2017
Q1 | $245M | Buy |
4,511,619
+847,534
| +23% | +$46.5M | 0.13% | 127 |
|
|
2016
Q4 | $214M | Buy |
3,664,085
+293,021
| +9% | +$16M | 0.12% | 145 |
|
|
2016
Q3 | $182M | Buy |
3,371,064
+199,860
| +6% | +$12.8M | 0.1% | 173 |
|
|
2016
Q2 | $233M | Buy |
3,171,204
+73,127
| +2% | +$5.17M | 0.14% | 118 |
|
|
2016
Q1 | $198M | Sell |
3,098,077
-34,180
| -1% | -$2.16M | 0.12% | 130 |
|
|
2015
Q4 | $215M | Sell |
3,132,257
-70,028
| -2% | -$4.63M | 0.14% | 118 |
|
|
2015
Q3 | $190M | Sell |
3,202,285
-330,255
| -9% | -$21M | 0.14% | 114 |
|
|
2015
Q2 | $235M | Buy |
3,532,540
+138,297
| +4% | +$9.11M | 0.16% | 97 |
|
|
2015
Q1 | $219M | Sell |
3,394,243
-539,700
| -14% | -$33.8M | 0.15% | 97 |
|
|
2014
Q4 | $232M | Buy |
3,933,943
+34,550
| +0.9% | +$1.95M | 0.15% | 98 |
|
|
2014
Q3 | $200M | Buy |
3,899,393
+723,219
| +23% | +$36.1M | 0.14% | 113 |
|
|
2014
Q2 | $154M | Sell |
3,176,174
-69,840
| -2% | -$3.44M | 0.1% | 143 |
|
|
2014
Q1 | $169M | Sell |
3,246,014
-623,859
| -16% | -$33.2M | 0.12% | 118 |
|
|
2013
Q4 | $206M | Buy |
3,869,873
+822,117
| +27% | +$41.9M | 0.15% | 109 |
|
|
2013
Q3 | $141M | Sell |
3,047,756
-924,924
| -23% | -$40.6M | 0.11% | 131 |
|
|
2013
Q2 | $178M | Buy |
+3,972,680
| New | +$172M | 0.15% | 98 |
|
Other funds holding BMY
VCM
VPM
Royal Bank of Canada's BMY Position: Q1 2026 in Review
Royal Bank of Canada reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, selling an estimated $98.2M and leaving 10,958,702 shares worth $665M. The position accounts for 0.12% of the portfolio, ranked #167.
Royal Bank of Canada first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $816M in Q1 2025. 2,522 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Royal Bank of Canada held 10,958,702 shares of Bristol-Myers Squibb worth $665M as of Q1 2026.
- Royal Bank of Canada sold 1,684,783 Bristol-Myers Squibb shares in Q1 2026, an estimated $98.2M.
- Bristol-Myers Squibb made up 0.12% of Royal Bank of Canada's portfolio in Q1 2026, its #167 holding.
- Royal Bank of Canada first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Bristol-Myers Squibb position peaked at $816M in Q1 2025.
- 2,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.